Japanese Journal of Clinical Oncology 34:46-49 (2004)
© 2004 Foundation for Promotion of Cancer Research
Late Pulmonary Metastasis of Renal Cell Carcinoma Resected 25 Years after Nephrectomy
1 Department of Thoracic Oncology, National Cancer Center Hospital East and 2 Pathology Division, National Cancer Center Research Institute East, Kashiwa, Chiba, Japan
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONCASE REPORTDISCUSSIONAcknowledgmentsREFERENCES |
|---|
A 50-year-old male underwent a left nephrectomy for clear cell type renal cell carcinoma (RCC) in February 1978. A right pulmonary metastasis was resected in February 1994. At that time, chest computed tomography revealed the presence of three small nodules in the left lung, but these were followed up as inflammatory lesions. In January 2002, a right pleural metastasis, which showed rapid growth, was detected and it was resected in June of the same year. A gradual growth was observed in the left lung nodules, and the patient underwent wedge resection of the left lung in March 2003, 25 years after nephrectomy. These nodules were diagnosed as metastatic RCC. Currently, the patient is doing well with no signs of recurrence, 8 months after the third metastasectomy.
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONCASE REPORTDISCUSSIONAcknowledgmentsREFERENCES |
|---|
Although pulmonary metastases of renal cell carcinoma (RCC) constitute the majority of cancer recurrences following nephrectomy, a disease-free interval of more than 20 years has rarely been reported. We previously reported an RCC patient with a metastatic pulmonary lesion resected 16 years after nephrectomy (1). During the postoperative follow-up, this patient underwent pleural metastasis extirpation in June 2002 and wedge resection of the left lung for pulmonary metastases in March 2003. To the best of our knowledge, the time interval between nephrectomy and metastasectomy is the longest ever reported in English literature from Japan. Therefore, this case is considered worthy of report.
|
CASE REPORT |
|---|
|
TOPABSTRACTINTRODUCTIONCASE REPORTDISCUSSIONAcknowledgmentsREFERENCES |
|---|
A 50-year-old male underwent left nephrectomy for RCC at a university hospital on February 2, 1978. The disease was histopathologically diagnosed as RCC, clear cell type, grade 1, and stage I. In August 1989, an abnormal shadow was detected in the left lung, but it disappeared shortly. This shadow was diagnosed as pleuritis. In September 1993, an abnormal X-ray shadow was detected in an annual health check-up, and the patient was referred to our institution. Computed tomography (CT) revealed a small nodule in the right lung. Video-assisted thoracoscopic wedge resection of the right lung was performed in February 1994, 16 years after nephrectomy. Pathological examination revealed that the tumor was metastatic clear cell type RCC (1).
Chest CT performed before the resection also revealed the presence of small nodules in the left inferior lingular segment and posterior basal segment (Fig. 1a). These were diagnosed as inflammatory nodules following pleuritis, and we decided to use CT to follow them up. CT scans were performed annually, and a pleural tumor adjacent to the right superior and inferior segment was detected in January 2002 (Fig. 2a). Since this tumor showed rapid growth on CT in May 2002 (Fig. 2b), the patient underwent a video-assisted thoracoscopic extirpation of the parietal pleural tumor on June 18, 2002. Histopathological examination demonstrated an RCC metastasis.
|
|
CT performed in February 2003 revealed evident growth of the left lung nodules (Fig. 1b). No evidence of other recurrences was detected. On the basis of the diagnosis of RCC metastasized to the left lung, we planned a third resection.
The patient presented no symptoms at the time of the third admission in March 2003. Physical examination revealed surgical scars on the abdomen and right-sided chest wall.
Video-assisted thoracoscopic wedge resection of the left lung was performed on March 19, 2003, 25 years after nephrectomy. Three nodules were present in the left inferior lingular and posterior basal segment. These nodules were resected along with the surrounding normal pulmonary parenchyma using stapling devices. No other lesions were thoracoscopically evident.
In macroscopic findings, the resected lung specimen revealed yellowish protruding tumors, visible immediately beneath the pleural surface. Microscopically, the lesion consisted of tumor cells growing in an alveolar pattern, separated by stroma, characteristically endowed with prominent sinusoid-like vessels. The tumor cells had abundant clear cytoplasm and uniform small ovoid hyperchromatic nuclei (Fig. 3a). These histological features are similar to those of the previously resected metastatic lesions (Fig. 3b). The tumor was diagnosed to be compatible with metastatic clear cell type RCC.
|
The postoperative course was uneventful. The patient was discharged on the 7th postoperative day. Currently, the patient is doing well, with no signs of recurrence, 8 months after the third metastasectomy.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONCASE REPORTDISCUSSIONAcknowledgmentsREFERENCES |
|---|
RCC frequently metastasizes to the lung. The prognosis of unresected metastatic RCC is poor. The 5-year survival rate of patients with metastatic RCC without surgical resection was only 9% (2). Chemotherapy, radiation therapy or immunotherapy has not proven effective for metastatic RCC. Surgical resection for pulmonary metastasis of RCC is a safe procedure (3–7). Complete surgical resection can result in long-term survival (5).
Piltz et al. (5) reported that the recurrence of resectable pulmonary metastases did not impair survival. This favors repeated resection. Pfannschmidt et al. (3) showed that the 5-year survival of patients undergoing repeated resection of pulmonary metastases did not differ from those with resection of a single metastatic lesion. Cerfolio et al. (4) stated that the 5-year survival rate of patients with repeated thoracotomy was similar to that observed for patients with a single thoracotomy. Fourquier et al. (7) reported the same result. These reports suggest that repeat metastasectomies are warranted. In this case, the repeated metastasectomies were safe and uneventful, and the patient is doing well, with no signs of further recurrence.
Poor prognosis following incomplete resection of RCC pulmonary metastasis has been reported. Pfannschmidt et al. (3) showed a 5-year survival rate of 22.1% in patients with incomplete resection as compared to 41.5% in patients with complete resection. Fourquier et al. (7) reported that one among five patients with incomplete resection survived for more than 3 years. However, Jett et al. reported that no difference in survival was detected in patients undergoing complete resection versus incomplete resection or biopsy only (8). Due to these contradictory reports, the role of resection of pulmonary RCC metastases remains unclear.
Pulmonary metastases of RCC with a long interval after nephrectomy have occasionally been reported. To our knowledge, there have been five cases with an interval of 20 years or more (Table 1). Froehner et al. (9) reported a case 20 years after nephrectomy. Jett et al. (8) reviewed their patients, and the maximum interval between nephrectomy and pulmonary resection was 20.5 years. The patient prognosis was not described. Donaldson et al. (10) reported a patient with two pulmonary metastases 24 years after nephrectomy. They performed a left lower lobectomy and right pulmonary wedge resection. A skin metastasis developed the next year, and the patient died of RCC 2 years after the lung resection. Bradham et al. (11) described a patient with pulmonary metastases 25 years after nephrectomy. Since the tumor had spread, only a part of it was removed for pathological confirmation. The patient died of RCC one year later. In a Japanese report having an English abstract, a 28-year interval was described. The patient was doing well without signs of further recurrence 4 years after resection of the metastatic lesion (12). Friedel et al. (2) reported that patients with a disease-free interval (DFI) of 48 months or more achieved a 5-year survival of 46% as compared to 26% for those with a DFI of less than 48 months. Pfannschmidt et al. (3) concluded that a long DFI was a favorable prognostic factor in cases of pulmonary RCC metastasis. The 5-year survival rate in patients with a DFI of more than 23 months was 47% as compared to 24.7% in patients with a DFI of 23 months or less. Cerfolio et al. (4) reported that patients with DFI more than 3.4 years had better survival rates. However, the prognostic information in patients with a DFI of 20 years or more (Table 1) raises a question regarding the role of the resection of RCC metastatic lesions. Two of the four cases with prognosis and description died of RCC following a relatively short course after resection of the metastasis. The other two were free of disease but for a relatively short follow-up period. In the present case, although, the left pulmonary metastases remained dormant for 10 years, the right pleural metastasis demonstrated a rapid growth. Longer DFI does not always imply slow tumor growth or absence of other metastases.
|
McNichols et al. reported that late RCC metastases are often combined with rapid disease progression (13). Late relapses after nephrectomy and prolonged stabilization of disease in the absence of systemic treatment and rare spontaneous regressions may suggest that host immune mechanisms are important in regulating tumor growth (14). However, these mechanisms have not yet been fully explored.
In conclusion, the literature data and lack of efficient therapeutic alternatives has lead to aggressive surgical resection of pulmonary RCC metastases being the treatment of choice. However, the true role of resection in management of pulmonary metastatic RCC, especially in patients with a very long DFI, is still unclear.
|
Acknowledgments |
|---|
|
TOPABSTRACTINTRODUCTIONCASE REPORTDISCUSSIONAcknowledgmentsREFERENCES |
|---|
The authors would like to express their gratitude to Prof. J. Patrick Barron of the International Medical Communications Center of Tokyo Medical University, Japan, for his review of the manuscript. This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare, Japan.
|
FOOTNOTES |
|---|
+ For reprints and all correspondence: Junji Yoshida, Department of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. E-mail: jyoshida{at}east.ncc.go.jp
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONCASE REPORTDISCUSSIONAcknowledgmentsREFERENCES |
|---|
1 Yoshida J, Nagai K, Hasebe T, Takahashi K, Nishimura M, Otsuka S, et al. Pulmonary metastasis of renal cell carcinoma resected sixteen years after nephrectomy. Jpn J Clin Oncol 1995;25:20–4.
2 Friedel G, Hürtgen M, Penzenstadler M, Kyriss T, Toomes H. Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 1999;19:1593–6.[ISI][Medline]
3 Pfannschmidt J, Hoffmann H, Muley T, Krysa S, Trainer C, Dienemann H. Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 2002;74:1653–7.
4 Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 1994;57:339–44.[Abstract]
5 Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma. Ann Thorac Surg 2002;73:1082–7.
6 van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FMJ. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 1999;35:197–203.[CrossRef][ISI][Medline]
7 Fourquier P, Regnard JF, Rea S, Levi JF, Levasseur P. Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg 1997;11:17–21.[Abstract]
8 Jett JR, Hollinger CG, Zinsmeister AR, Pairolero PC. Pulmonary resection of metastatic renal cell carcinoma. Chest 1983;84:442–5.
9 Froehner M, Manseck A, Lossnitzer A, Wirth MP. Late local and pulmonary recurrence of renal cell carcinoma. Urol Int 1998;60:248–50.[CrossRef][ISI][Medline]
10 Donaldson JC, Slease RB, DuFour DR, Saltzman AR. Metastatic renal cell carcinoma 24 years after nephrectomy. JAMA 1976;236:950–1.[Abstract]
11 Bradham RR, Wannamaker CC, Pratt-Thomas HR. Renal cell carcinoma metastases 25 years after nephrectomy. JAMA 1973;223:921–2.[CrossRef][ISI][Medline]
12 Yoshikawa K, Morimoto M. A case of pulmonary metastasis of renal cell carcinoma 28 years after nephrectomy. Jpn J Chest Surg 1998;12:792–5 (in Japanese).
13 McNichols DW, Segura JW, DeWeerd JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol 1981;126:17–23.[ISI][Medline]
14 Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865–75.
Received September 15, 2003; accepted December 6, 2003
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Kobayashi, T. Yamaguchi, T. Ishihara, H. Tadenuma, K. Nakamura, T. Ohshima, N. Sakaue, T. Baba, M. Yoshikawa, and H. Saisho Spontaneous Rupture of Pancreatic Metastasis from Renal Cell Carcinoma Jpn. J. Clin. Oncol., November 1, 2004; 34(11): 696 - 699. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||